Abstract
Photodermatology, Photoimmunology & PhotomedicineVolume 15, Issue 1 p. 37-38 Free Access Malignant melanoma in patients treated for psoriasis with PUVA R. S. Stern, Corresponding Author R. S. Stern Harvard Medical School, Boston, Massachusetts, USABeth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, USASearch for more papers by this author R. S. Stern, Corresponding Author R. S. Stern Harvard Medical School, Boston, Massachusetts, USABeth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, USASearch for more papers by this author First published: 13 February 2009 https://doi.org/10.1111/j.1600-0781.1999.tb00052.xCitations: 18AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study. Cancer 1994: 73: 2759– 2764. 2 Klecak G., Urbach F., Urwyler H. Fluoroquinolone antibacterials enhance UVA-induced skin tumors. J Photochem Photobiol 1997: 37: 174– 181. 3 Abdel-Naser MB, Hann SK, Bystryn JC. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation. Arch Dermatol 1997: 133: 1530– 1533. 4 Roelandts R. Mutagenicity and carcinogenicity of methoxsalen plus UV-A. Arch Dermatol 1984: 120: 662– 669. 5 Rhodes AR, Stern RS, Melski JW. The PUVA lentigo: analysis of predisposing factors. J Invest Dermatol 1983: 81: 459– 463. 6 Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997: 336: 1041– 1045. Citing Literature Volume15, Issue1February 1999Pages 37-38 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Photodermatology, Photoimmunology & Photomedicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
